Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2)
Public ClinicalTrials.gov record NCT04140695. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled, Efficacy Study of the Neurokinin-1 Receptor Antagonist VLY-686 in Patients With Atopic Dermatitis
Study identification
- NCT ID
- NCT04140695
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Vanda Pharmaceuticals
- Industry
- Enrollment
- 87 participants
Conditions and interventions
Conditions
Interventions
- Tradipitant Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 20, 2019
- Primary completion
- Oct 13, 2020
- Completion
- Oct 13, 2020
- Last update posted
- May 13, 2024
2019 – 2020
United States locations
- U.S. sites
- 51
- U.S. states
- 28
- U.S. cities
- 46
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vanda Investigational Site | Hoover | Alabama | 35244 | — |
| Vanda Investigational Site | Tempe | Arizona | 85281 | — |
| Vanda Investigational Site | Encino | California | 91436 | — |
| Vanda Investigational Site | Fountain Valley | California | 92708 | — |
| Vanda Investigational Site | Laguna Hills | California | 92653 | — |
| Vanda Investigational Site | Lomita | California | 90717 | — |
| Vanda Investigational Site | Los Angeles | California | 90025 | — |
| Vanda Investigational Site | Los Angeles | California | 90036 | — |
| Vanda Investigational Site | Los Angeles | California | 90057 | — |
| Vanda Investigational Site | Denver | Colorado | 80220 | — |
| Vanda Investigational Site | Clearwater | Florida | 33756 | — |
| Vanda Investigational Site | Miami | Florida | 33126 | — |
| Vanda Investigational Site | Tampa | Florida | 33613 | — |
| Vanda Investigational Site | Savannah | Georgia | 31406 | — |
| Vanda Investigational Site | Boise | Idaho | 83704 | — |
| Vanda Investigational Site | Chicago | Illinois | 60611 | — |
| Vanda Investigational Site | Normal | Illinois | 61761 | — |
| Vanda Investigational Site | Skokie | Illinois | 60077 | — |
| Vanda Investigational Site | Plainfield | Indiana | 46168 | — |
| Vanda Investigational Site | Crowley | Louisiana | 70526 | — |
| Vanda Investigational Site | Timonium | Maryland | 21093 | — |
| Vanda Investigational Site | Fort Gratiot | Michigan | 48059 | — |
| Vanda Investigational Site | Saint Joseph | Missouri | 64506 | — |
| Vanda Investigational Site | St Louis | Missouri | 63141 | — |
| Vanda Investigational Site | Omaha | Nebraska | 68144 | — |
| Vanda Investigational Site | Las Vegas | Nevada | 89119 | — |
| Vanda Investigational Site | Berlin | New Jersey | 08009 | — |
| Vanda Investigational Site | Hoboken | New Jersey | 07030 | — |
| Vanda Investigational Site | Verona | New Jersey | 07044 | — |
| Vanda Investigational Site | Kew Gardens | New York | 11415 | — |
| Vanda Investigational Site | New York | New York | 10022 | — |
| Vanda Investigational Site | New York | New York | 10075 | — |
| Vanda Investigational Site | The Bronx | New York | 10458 | — |
| Vanda Investigational Site | Charlotte | North Carolina | 28277 | — |
| Vanda Investigational Site | Cincinnati | Ohio | 45212 | — |
| Vanda Investigational Site | Oklahoma City | Oklahoma | 73112 | — |
| Vanda Investigational Site | Tulsa | Oklahoma | 74136 | — |
| Vanda Investigational Site | Philadelphia | Pennsylvania | 19103 | — |
| Vanda Investigational Site | Johnston | Rhode Island | 02919 | — |
| Vanda Investigational Site | Spartanburg | South Carolina | 29301 | — |
| Vanda Investigational Site | Spartanburg | South Carolina | 29303 | — |
| Vanda Investigational Site | Dallas | Texas | 75230 | — |
| Vanda Investigational Site | Houston | Texas | 77004 | — |
| Vanda Investigational Site | Houston | Texas | 77065 | — |
| Vanda Investigational Site | Mesquite | Texas | 75149 | — |
| Vanda Investigational Site | South Jordan | Utah | 84095 | — |
| Vanda Investigational Site | South Burlington | Vermont | 05403 | — |
| Vanda Investigational Site | Alexandria | Virginia | 22311 | — |
| Vanda Investigational Site | Newport News | Virginia | 23606 | — |
| Vanda Investigational Site | Norfolk | Virginia | 23502 | — |
| Vanda Investigational Site | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04140695, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 13, 2024 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04140695 live on ClinicalTrials.gov.